Abstract
Background: Selective serotonin reuptake inhibitors (SSRI) are commonly used for the treatment of depression and anxiety. Inhibition of serotonin reuptake in platelets increases bleeding risk in patients taking SSRIs. Case: Here, we present the case of a 52-year-old patient who developed severe postsurgical bleeding requiring blood transfusion following panniculectomy. Conclusion: SSRI-induced bleeding is dose-related and strongly influenced by individual variations in drug metabolizing enzymes and transporters.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 117-121 |
| Number of pages | 5 |
| Journal | Drugs in R and D |
| Volume | 24 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2024 |
ASJC Scopus subject areas
- Pharmacology